Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors
Clinical trial NCT05495828 · UNKNOWN
Trial details
- NCT number
- NCT05495828
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-10
- Primary completion
- 2024-12-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.